Wealth Management

EfTEN United Property Fund's large cash payout caused a NAV dip, raising questions amid lower profits. But a look at its accounting and portfolio reveals a story of strategic capital return.

The financial giant sets its 2027 Investor Day. Beyond the date, it's a signal of intent for navigating a fractured world with a $4.9T balance sheet.

Targeting advisor frustration, Wallace Finance launches a unified AI platform for wealth managers, aiming to cut costs and democratize advanced investing.

A new partnership between Merit Financial and Prizm highlights a major industry shift. Technology is finally enabling a truly holistic view of wealth.

RBC's mid-year outlook reveals a resilient bull market powered by stellar earnings, but warns of historical volatility as yields and election risks loom.

Moneta's appointment of a growth veteran isn't just a new hire; it's a calculated move in the high-stakes chess game of wealth management expansion.

A new Bernstein report reveals UHNW families are prioritizing internal resilience and next-gen prep over external market fears, driven by new laws and a deep generational divide.

Vendors hold the cards in IT renewals. A new platform aims to change that by arming enterprises with pre-quote intelligence to secure better deals.

With its new hire, John Gotsch, Fiduciary Trust of New England leverages fresh capital to double down on specialized trust services for the ultra-wealthy.

With a landmark therapy for Sanfilippo Syndrome nearing the FDA, Spruce adds veteran marketing and finance chiefs. A look at the talent behind the transition.

As AI devalues technical skills, a new framework argues your lived experience is becoming priceless. Discover how to leverage your 'Masterwork Years' for lasting impact.

Lexeo Therapeutics finalizes a pivotal trial for its Friedreich ataxia gene therapy, leveraging a novel trial design and accelerated FDA pathway.

Dominari Securities' successful $200M fund for the SpaceX IPO isn't just a trade; it's a masterclass in the new mechanics of power and profit on Wall Street.

A forum in Xiamen unveils a RMB 9.1 billion push for financial integration, but is it just about business, or a deeper play for Taiwan's future?

After its transformative Plains NGL acquisition, Keyera unveils an aggressive growth plan targeting 16% CAGR, promising a new era of shareholder value.

While biopharma braces for Medicare price negotiations, Halozyme claims immunity. Is its tech-licensing model the new blueprint for resilience or just a loophole?

A new survey shows Asians value independence over inheritance, yet a massive gap between intention and action threatens to derail their plans for self-reliance.

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

A new FDA-designated device aims to filter a deadly protein from the blood of sepsis patients. Can this novel approach finally conquer a global health crisis?

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.